PITTSBURGH (AP) — A western Pennsylvania oncology practice has been fined $100,000 after acknowledging it bought nearly $1 million worth of non-federally approved cancer drugs from foreign suppliers.
Federal prosecutors in San Diego announced that Pittsburgh-based Jan C. Seski, M.D. & Associates received the drugs through a southern California supplier between December 2008 and May 2011.
Officials with the practice pleaded guilty on behalf of the business and agreed to pay the fine and to place paid ads warning that such drugs are dangerous in two medical journals.
Federal prosecutors say tests indicated the drugs had the proper active ingredients, but the labels didn’t meet U.S. Food and Drug Administration standards, which means there was no assurance the drugs were genuine.